14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for ENZC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0044 15.14 %
R2 0.0042 10.16 %
R1 0.0041 7.08 %
Current price: 0.0038
Support S1 0.0037 -2.90 %
S2 0.0036 -5.98 %
S3 0.0034 -10.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0044 14.88 %
R2 0.0043 12.27 %
R1 0.0039 1.83 %
Current price 0.0038
Support S1 0.0037 -2.35%
S2 0.0035 -8.62%
S3 0.0029 -24.28%

ENZC Predictions History

3 years ago
Max Weber predicted that ENZC for 2021-03-29 is going

Rank:

3 years ago
Jon Frincke predicted that ENZC for 2021-03-29 is going

Rank:

3 years ago
claudia_162001 predicted that ENZC for 2021-03-10 is going

Rank:

3 years ago
JS predicted that ENZC for 2021-03-10 is going $0.381 (10.43%)

3 years ago
lily12317 predicted that ENZC for 2021-03-10 is going $0.385 (0.00%)

Rank:

3 years ago
You Decide Say What predicted that ENZC for 2021-03-09 is going $0.440 (14.32%)

Rank:

3 years ago
lily12317 predicted that ENZC for 2021-03-09 is going $0.425 (0.00%)

Rank:

3 years ago
JS predicted that ENZC for 2021-03-08 is going $0.461 (8.47%)

3 years ago
JS predicted that ENZC for 2021-03-05 is going $0.220 (-43.30%)

3 years ago
lily12317 predicted that ENZC for 2021-03-05 is going $0.264 (-31.95%)

Rank:
Click to get the best stock tips daily for free!

About Enzolytics Inc

Enzolytics Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell l... ENZC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT